These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38043270)

  • 1. An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3.
    Wang X; Yan L; Guo J; Jia R
    Int Immunopharmacol; 2024 Jan; 126():111280. PubMed ID: 38043270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3.
    Wang J; Yan L; Wang X; Jia R; Guo J
    Inflamm Res; 2024 Jul; 73(7):1123-1135. PubMed ID: 38698180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
    Sun Y; Yan L; Guo J; Shao J; Jia R
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
    Xu L; Shen J; Jia J; Jia R
    Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
    Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
    Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides.
    Guo J; Che X; Wang X; Jia R
    RSC Adv; 2018 Feb; 8(13):7159-7163. PubMed ID: 35540349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 Exon 3 Is a Hidden Switch of Its Expression and Function in Oral Cancer Cells.
    Yan L; Sun Y; Guo J; Jia R
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon 9 skipping of apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through interaction with exon 8.
    Jang HN; Lee M; Loh TJ; Choi SW; Oh HK; Moon H; Cho S; Hong SE; Kim DH; Sheng Z; Green MR; Park D; Zheng X; Shen H
    Biochim Biophys Acta; 2014 Jan; 1839(1):25-32. PubMed ID: 24321384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
    Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
    RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.
    Dewaele M; Tabaglio T; Willekens K; Bezzi M; Teo SX; Low DH; Koh CM; Rambow F; Fiers M; Rogiers A; Radaelli E; Al-Haddawi M; Tan SY; Hermans E; Amant F; Yan H; Lakshmanan M; Koumar RC; Lim ST; Derheimer FA; Campbell RM; Bonday Z; Tergaonkar V; Shackleton M; Blattner C; Marine JC; Guccione E
    J Clin Invest; 2016 Jan; 126(1):68-84. PubMed ID: 26595814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of
    Sun J; Bai J; Jiang T; Gao Y; Hua Y
    RNA Biol; 2019 Dec; 16(12):1794-1805. PubMed ID: 31441370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRSF3-Mediated Ki67 Exon 7-Inclusion Promotes Head and Neck Squamous Cell Carcinoma Progression via Repressing AKR1C2.
    Liu M; Lin C; Huang Q; Jia J; Guo J; Jia R
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the regulatory effects of synthesized antisense oligonucleotides on androgen receptor (AR) exon 3 splicing in prostate cancer cells.
    Wang L; Gong S; Zhang X; Azhar Z; Chen J
    Gene; 2023 May; 866():147330. PubMed ID: 36871670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
    Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
    J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
    Guo J; Jia J; Jia R
    Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
    DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
    Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
    Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
    Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB.
    Khoo B; Roca X; Chew SL; Krainer AR
    BMC Mol Biol; 2007 Jan; 8():3. PubMed ID: 17233885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides.
    Wang Z; Jeon HY; Rigo F; Bennett CF; Krainer AR
    Open Biol; 2012 Oct; 2(10):120133. PubMed ID: 23155487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.